Compile Data Set for Download or QSAR
maximum 50k data
Found 234 Enz. Inhib. hit(s) with all data for entry = 7334
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189942(US9175003, 27)
Affinity DataEC50:  843nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189943(US9175003, 31)
Affinity DataEC50:  657nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189944(US9175003, 40)
Affinity DataEC50:  310nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189945(US9175003, 51)
Affinity DataEC50:  410nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189946(US9175003, 53)
Affinity DataEC50:  380nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189947(US9175003, 55)
Affinity DataEC50:  360nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189948(US9175003, 60)
Affinity DataEC50:  109nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189949(US9175003, 61)
Affinity DataEC50:  73nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189950(US9175003, 62)
Affinity DataEC50:  328nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189951(US9175003, 63)
Affinity DataEC50:  277nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189952(US9175003, 65)
Affinity DataEC50:  434nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189953(US9175003, 70)
Affinity DataEC50:  259nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189954(US9175003, 71)
Affinity DataEC50:  477nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189955(US9175003, 72)
Affinity DataEC50:  480nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189956(US9175003, 73)
Affinity DataEC50:  76nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189957(US9175003, 81)
Affinity DataEC50:  326nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189958(US9175003, 85)
Affinity DataEC50:  263nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189959(US9175003, 86)
Affinity DataEC50:  249nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189960(US9175003, 87)
Affinity DataEC50:  67nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189961(US9175003, 88)
Affinity DataEC50:  75nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189962(US9175003, 92)
Affinity DataEC50:  156nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189963(US9175003, 95)
Affinity DataEC50:  462nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189964(US9175003, 96)
Affinity DataEC50:  185nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189965(US9175003, 98)
Affinity DataEC50:  377nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189966(US9175003, 105)
Affinity DataEC50:  321nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189967(US9175003, 108)
Affinity DataEC50:  70nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189968(US9175003, 109)
Affinity DataEC50:  298nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189969(US9175003, 110)
Affinity DataEC50:  356nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189970(US9175003, 111)
Affinity DataEC50:  44nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189971(US9175003, 112)
Affinity DataEC50:  48nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189972(US9175003, 114)
Affinity DataEC50:  232nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189973(US9175003, 115)
Affinity DataEC50:  163nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189974(US9175003, 119)
Affinity DataEC50:  131nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189975(US9175003, 120)
Affinity DataEC50:  264nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189976(US9175003, 126)
Affinity DataEC50:  312nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189977(US9175003, 128)
Affinity DataEC50:  178nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189978(US9175003, 130)
Affinity DataEC50:  111nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189979(US9175003, 132)
Affinity DataEC50:  214nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189980(US9175003, 133)
Affinity DataEC50:  54nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189981(US9175003, 135)
Affinity DataEC50:  284nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189982(US9175003, 136)
Affinity DataEC50:  50nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189983(US9175003, 138)
Affinity DataEC50:  241nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189984(US9175003, 139)
Affinity DataEC50:  85nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189985(US9175003, 141)
Affinity DataEC50:  315nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189986(US9175003, 142)
Affinity DataEC50:  263nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189987(US9175003, 144)
Affinity DataEC50:  245nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189988(US9175003, 147)
Affinity DataEC50:  5nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189989(US9175003, 148 | US9175003, 179)
Affinity DataEC50:  13nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189990(US9175003, 149)
Affinity DataEC50:  26nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Vtv Therapeutics

US Patent
LigandPNGBDBM189991(US9175003, 150)
Affinity DataEC50:  372nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 234 total ) | Next | Last >>
Jump to: